Furthermore, AMACR was expressed in 90 % (46 of 51) of NEC cases, where 50 % (23 of 46) showed strong staining, 35 % (15 of 46) showed intermediate staining and 15 % (7 of 46) weak staining. The gene discussed is AMACR; the disease is neuroendocrine carcinoma.